Sustained Avastin aids colon cancer survival-study

Sustained Avastin aids colon cancer survival-study | Reuters.

LOS ANGELES (Reuters) – Colorectal cancer patients who continued treatment with Roche Holding AG’s Avastin even after their cancer worsened lived longer than those who went off the drug, according to an “observational analysis” released on Thursday.



5 thoughts on “Sustained Avastin aids colon cancer survival-study”

Leave a Reply

Your email address will not be published. Required fields are marked *